Literature DB >> 15639781

Brain plasticity and antidepressant treatments: new cells, new connections.

Ian C Reid1, Caroline A Stewart.   

Abstract

It is now a decade since we first wrote about the impact of antidepressant agents on plastic processes in the hippocampus (Stewart and Reid, 1993). Since then, the roles of various forms of brain plasticity have moved centre stage in efforts to understand the pathophysiology of depressive disorder. Here, we review the background to current views relating cytoarchitectural and synaptic changes to the aetiology and treatment of affective disease.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15639781     DOI： 10.1007/BF03033285

Source DB:  PubMed          Journal:  Neurotox Res        ISSN： 1029-8428            Impact factor:   3.911


  52 in total

1.  Adult-generated hippocampal and neocortical neurons in macaques have a transient existence.

Authors:  E Gould; N Vail; M Wagers; C G Gross
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Enhancement of hippocampal neurogenesis by lithium.

Authors:  G Chen; G Rajkowska; F Du; N Seraji-Bozorgzad; H K Manji
Journal:  J Neurochem       Date:  2000-10       Impact factor: 5.372

3.  Effects of adult neurogenesis on synaptic plasticity in the rat dentate gyrus.

Authors:  J S Snyder; N Kee; J M Wojtowicz
Journal:  J Neurophysiol       Date:  2001-06       Impact factor: 2.714

4.  Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents.

Authors:  Alison C Shakesby; Roger Anwyl; Michael J Rowan
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

5.  Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study.

Authors:  P J Shah; K P Ebmeier; M F Glabus; G M Goodwin
Journal:  Br J Psychiatry       Date:  1998-06       Impact factor: 9.319

6.  Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.

Authors:  Eiji Shimizu; Kenji Hashimoto; Naoe Okamura; Kaori Koike; Naoya Komatsu; Chikara Kumakiri; Michiko Nakazato; Hiroyuki Watanabe; Naoyuki Shinoda; Sin-ichi Okada; Masaomi Iyo
Journal:  Biol Psychiatry       Date:  2003-07-01       Impact factor: 13.382

7.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

8.  Ketamine prevents ECS-induced synaptic enhancement in rat hippocampus.

Authors:  C A Stewart; I C Reid
Journal:  Neurosci Lett       Date:  1994-08-29       Impact factor: 3.046

9.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Arrested neuronal proliferation and impaired hippocampal function following fractionated brain irradiation in the adult rat.

Authors:  T M Madsen; P E G Kristjansen; T G Bolwig; G Wörtwein
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590
View more
  3 in total

Review 1.  Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications.

Authors:  Daniela Jezova
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

Review 2.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 3.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.